104 related articles for article (PubMed ID: 15179824)
1. [Cysteine proteinases and their inhibitors in the development of mouse HA-1 hepatoma and antineoplastic therapy].
Poteriaeva ON; Korolenko TA; Svechnikova IG; Zhanaeva SIa; Falameeva OV; Kaledin VI; Nowicky JW
Biomed Khim; 2004; 50(2):172-9. PubMed ID: 15179824
[TBL] [Abstract][Full Text] [Related]
2. Cysteine proteinase inhibitor level in tumor and normal tissues in control and cured mice.
Poteryaeva ON; Falameyeva OV; Korolenko TA; Kaledin VI; Djanayeva SJ; Nowicky JW; Sandula J
Drugs Exp Clin Res; 2000; 26(5-6):301-6. PubMed ID: 11345042
[TBL] [Abstract][Full Text] [Related]
3. The influence of Ukrain on the growth of HA-1 tumor in mice: the role of cysteine proteinases as markers of tumor malignancy.
Svechnikova IG; Korolenko TA; Stashko JuF ; Kaledin VI; Nikolin VP; Nowicky JW
Drugs Exp Clin Res; 1998; 24(5-6):261-9. PubMed ID: 10190085
[TBL] [Abstract][Full Text] [Related]
4. Cystatin C in LS lymphosarcoma and HA-1 hepatoma treated with Ukrain and cyclophosphamide and involvement of apoptosis.
Korolenko TA; Poteryaeva ON; Djanayeva SJ; Svechnikova IG; Kaledin VI; Timofeyeva OA; Filipenko ML; Nowicky J
Drugs Exp Clin Res; 2000; 26(5-6):285-92. PubMed ID: 11345040
[TBL] [Abstract][Full Text] [Related]
5. Expression of cysteine proteinases cathepsins B and K and of cysteine proteinase inhibitor cystatin C in giant cell tumor of tendon sheath.
Hansen T; Petrow PK; Gaumann A; Keyszer GM; Otto M; Kirkpatrick CJ; Kriegsmann J
Mod Pathol; 2001 Apr; 14(4):318-24. PubMed ID: 11301348
[TBL] [Abstract][Full Text] [Related]
6. Role of cystatin C and cysteine proteinases in the development of mouse LS-lymphosarcoma.
Poteryaeva ON; Falameeva OV; Zhanaeva SY; Svechnikova IG; Korolenko TA; Kaledin VI
Bull Exp Biol Med; 2001 Jul; 132(1):675-7. PubMed ID: 11687851
[TBL] [Abstract][Full Text] [Related]
7. Influence of Ukrain and cyclophosphamide administration on HA-1 murine hepatoma and LS lymphoma on aspartic proteinase cathepsin D.
Djanayeva SJ; Korolenko TA; Svechnikova IG; Falameyeva OV; Korolenko E; Kaledin VI; Nowicky J
Drugs Exp Clin Res; 2000; 26(5-6):293-9. PubMed ID: 11345041
[TBL] [Abstract][Full Text] [Related]
8. Cysteine proteases and cysteine protease inhibitors in non-small cell lung cancer.
Krepela E; Procházka J; Kárová B; Cermák J; Roubková H
Neoplasma; 1998; 45(5):318-31. PubMed ID: 9921922
[TBL] [Abstract][Full Text] [Related]
9. The role of Gly-4 of human cystatin A (stefin A) in the binding of target proteinases. Characterization by kinetic and equilibrium methods of the interactions of cystatin A Gly-4 mutants with papain, cathepsin B, and cathepsin L.
Estrada S; Nycander M; Hill NJ; Craven CJ; Waltho JP; Björk I
Biochemistry; 1998 May; 37(20):7551-60. PubMed ID: 9585570
[TBL] [Abstract][Full Text] [Related]
10. Macrophage stimulation and antitumor effect of Ukrain.
Korolenko TA; Svechnikova IG; Filjushina EE; Kaledin VI; Vakulin GM; Usynin IF; Tsyrendordjiev DD
Drugs Exp Clin Res; 1998; 24(5-6):253-60. PubMed ID: 10190084
[TBL] [Abstract][Full Text] [Related]
11. Differential localization of cysteine protease inhibitors and a target cysteine protease, cathepsin B, by immuno-confocal microscopy.
Calkins CC; Sameni M; Koblinski J; Sloane BF; Moin K
J Histochem Cytochem; 1998 Jun; 46(6):745-51. PubMed ID: 9603786
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of cathepsins B and L compared with matrix metalloproteinases and their respective inhibitors in rheumatoid arthritis and osteoarthritis: a parallel investigation by semiquantitative reverse transcriptase-polymerase chain reaction and immunohistochemistry.
Keyszer G; Redlich A; Häupl T; Zacher J; Sparmann M; Engethüm U; Gay S; Burmester GR
Arthritis Rheum; 1998 Aug; 41(8):1378-87. PubMed ID: 9704635
[TBL] [Abstract][Full Text] [Related]
13. Different cysteine proteinases involved in bone resorption and osteoclast formation.
Brage M; Abrahamson M; Lindström V; Grubb A; Lerner UH
Calcif Tissue Int; 2005 Jun; 76(6):439-47. PubMed ID: 15906014
[TBL] [Abstract][Full Text] [Related]
14. Grafting of features of cystatins C or B into the N-terminal region or second binding loop of cystatin A (stefin A) substantially enhances inhibition of cysteine proteinases.
Pavlova A; Björk I
Biochemistry; 2003 Sep; 42(38):11326-33. PubMed ID: 14503883
[TBL] [Abstract][Full Text] [Related]
15. Cystein proteinase inhibitor stefin A as an indicator of efficiency of tumor treatment in mice.
Korolenko TA; Poteryaeva ON; Falameeva OV; Levina OA
Bull Exp Biol Med; 2003 Jul; 136(1):46-8. PubMed ID: 14534608
[TBL] [Abstract][Full Text] [Related]
16. Role of the single cysteine residue, Cys 3, of human and bovine cystatin B (stefin B) in the inhibition of cysteine proteinases.
Pol E; Björk I
Protein Sci; 2001 Sep; 10(9):1729-38. PubMed ID: 11514663
[TBL] [Abstract][Full Text] [Related]
17. The importance of the second hairpin loop of cystatin C for proteinase binding. Characterization of the interaction of Trp-106 variants of the inhibitor with cysteine proteinases.
Björk I; Brieditis I; Raub-Segall E; Pol E; Håkansson K; Abrahamson M
Biochemistry; 1996 Aug; 35(33):10720-6. PubMed ID: 8718861
[TBL] [Abstract][Full Text] [Related]
18. Human cysteine proteinases and their protein inhibitors stefins, cystatins and kininogens.
Turk V; Brzin J; Kotnik M; Lenarcic B; Popović T; Ritonja A; Trstenjak M; Begić-Odobasić L; Machleidt W
Biomed Biochim Acta; 1986; 45(11-12):1375-84. PubMed ID: 3495261
[TBL] [Abstract][Full Text] [Related]
19. Human recombinant pro-dipeptidyl peptidase I (cathepsin C) can be activated by cathepsins L and S but not by autocatalytic processing.
Dahl SW; Halkier T; Lauritzen C; Dolenc I; Pedersen J; Turk V; Turk B
Biochemistry; 2001 Feb; 40(6):1671-8. PubMed ID: 11327826
[TBL] [Abstract][Full Text] [Related]
20. Cathepsins B and L and their inhibitors stefin B and cystatin C as markers for malignant progression of benign meningiomas.
Trinkaus M; Vranic A; Dolenc VV; Lah TT
Int J Biol Markers; 2005; 20(1):50-9. PubMed ID: 15832773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]